Monday, May 13, 2024 7:12:31 PM
JFR,
I believe that if you look at LP's background there is no shortage of bankers she could be speaking with. I know I'll sound like a believe the company is going after the shorts, the MM's, etc. but Posner's efforts are already saying that. What better way of getting these people than to allow them to think they have time, and suddenly spring approval on them. I don't know this is happening, but whether it's by next week, or by the middle of next month barring a major change in the share price before, indicating they're clearing out of their short position, we could see the mother of all short squeezes.
As I understand it, we're just a few weeks from also knowing that the MM's have no more MTD available to them, if they don't get a dismissal they'll either be going to trial, or they'll settle. I know none of this happens quickly unless they determine they want it behind them with a quick settlement rather than having it hanging over their heads for years.
I know I sound like a conspiracy theorist in saying, this, that's okay. If I'm wrong, no harm done, if I'm right, we'll all be far better off quickly. I know that DI wouldn't say, you're right, or your wrong, he just doesn't work that way. Frankly I don't believe that DI is aware of all the company is planning so that he does have deniability for not providing false information. He could very well be planning a PR campaign for after approval, or for the release of new information on the EDEN or other things without having any knowledge of when events were anticipated to happen. I know that DI has told other investors that the company plans to roll out more than just approval, once they have approval, I'm sure he's working on that, but the timing is clearly an unknown, at least to him, and I doubt if the company knows much about it.
Gary
I believe that if you look at LP's background there is no shortage of bankers she could be speaking with. I know I'll sound like a believe the company is going after the shorts, the MM's, etc. but Posner's efforts are already saying that. What better way of getting these people than to allow them to think they have time, and suddenly spring approval on them. I don't know this is happening, but whether it's by next week, or by the middle of next month barring a major change in the share price before, indicating they're clearing out of their short position, we could see the mother of all short squeezes.
As I understand it, we're just a few weeks from also knowing that the MM's have no more MTD available to them, if they don't get a dismissal they'll either be going to trial, or they'll settle. I know none of this happens quickly unless they determine they want it behind them with a quick settlement rather than having it hanging over their heads for years.
I know I sound like a conspiracy theorist in saying, this, that's okay. If I'm wrong, no harm done, if I'm right, we'll all be far better off quickly. I know that DI wouldn't say, you're right, or your wrong, he just doesn't work that way. Frankly I don't believe that DI is aware of all the company is planning so that he does have deniability for not providing false information. He could very well be planning a PR campaign for after approval, or for the release of new information on the EDEN or other things without having any knowledge of when events were anticipated to happen. I know that DI has told other investors that the company plans to roll out more than just approval, once they have approval, I'm sure he's working on that, but the timing is clearly an unknown, at least to him, and I doubt if the company knows much about it.
Gary
Bullish
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
